Events & Presentations
- Jul. 01,Boston Scientific To Webcast Second Quarter 2015 Earnings Call On July 23
- Jun. 22,Boston Scientific Initiates Global Study To Assess EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) In Primary Prevention Patients With Low Ejection Fraction
About Boston Scientific
Boston Scientific (NYSE: BSX) transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit us at www.bostonscientific.com.